Bruna Cristina Alves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bruna Cristina Alves has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Brayan Jonas Mano-Sousa
Federal University of São João del Rei
3 shared publications - Joaquim Maurício Duarte-Almeida
Plant Cell Culture Laboratory, Federal University of São João del Rei (UFSJ), Chanadour, Divinópolis, Brazil
2 shared publications - Alex Gutterres Taranto
Laboratory of Bioinformatics and Drug Design, Department of Biotechnology, Federal University of São João del Rei, Praça Dom Helvécio, 74, Dom Bosco, Minas Gerais, São João del-Rei 36301-160, MG, Brazil
1 shared publication Ana Clara Anacleto Gonçalves
Campus Centro-Oeste, Universidade Federal de São João del-Rei, Divinópolis, Minas Gerais, Brazil
1 shared publication- Christiane Fátima Oliveira
Universidade Federal de São João del-Rei
1 shared publication - Frank Pereira de Andrade
Universidade Federal de São João del-Rei
1 shared publication
Latest Publications
- 1 February 2024
- Published by SAGE Publications in Cannabis & Cannabinoid Research
- Vol. 9 (1) , 21-34
Bibliometric Analysis of Cannabis sativa Research: Trends, Challenges, and Future Directions
Introduction: The use of medical Cannabis remains unregulated in several countries due to the scarcity of clinical studies with high scientific evidence that establish safety and efficacy of Cannabis products. This study aimed to comprehensively analyze how knowledge has been created in this field, as well as perform a bibliographic mapping to identify knowledge gaps, and investigate key authors and journals that have significantly contributed to advancing our understanding of Cannabis . Method: The study protocol was registered in the International Prospective Register of Systematic Review (CRD42020223084). A systematic search was conducted in the Cochrane Central Register of Controlled Trials, Lilacs, Google Scholar, PubMed, SciELO, Scopus, and Web of Science databases. The bibliographic analysis and mapping were registered using the VOSviewer, Sci2tool, CiteSpace, and PoP software. Results: The systematic search identified 27,597 records, with 17,020 duplicates, resulting in a total of 10,577 articles included. The authors who published the most were Marilyn Ann Huestis ( n =108) and Sagnik Bhattacharyya ( n =71), while Elisaldo A. Carlini and Raphael Mechoulam published 8 and 22 articles, respectively. The journals Drug and Alcohol Dependence ( n =297), Psychopharmacology ( n =159) and Addictive Behaviors ( n =150) were the ones that published the most on Cannabis . The journals suggest that the articles are correlated with the adverse and toxicological effects of recreational Cannabis use; however, most articles focus on medical Cannabis . The peak of publications was in 2021 ( n =1,481). The countries that published the most were the United States ( n =9,735), while Brazil occupied the 11th position ( n =422). Most publications were carried out in “Pharmacology and Pharmacy” (11.31%), followed by “Psychiatry” (7.66%) and “Medicine” (5.80%). The areas of “Neurosciences” (1.59%), “Biochemistry,” “Genetics,” and “Molecular Biology” (0.79%) were little explored. Conclusion: This study captured the characteristics of publications about Cannabis and clinical studies in the scientific literature, yielding >10,000 articles, representing a large literature review, to date. Therefore, the most productive countries included the United States, the United Kingdom, and Canada, while the most productive authors were Marilyn Ann Huestis and Sagnik Bhattacharyya, with a peak of publications in 2021. Finally, the most chosen journals were Drug and Alcohol Dependence and Psychopharmacology .
- 1 February 2024
- Published by SAGE Publications in Cannabis & Cannabinoid Research
- Vol. 9 (1) , 21-34
Bibliometric Analysis of Cannabis sativa Research: Trends, Challenges, and Future Directions
Introduction: The use of medical Cannabis remains unregulated in several countries due to the scarcity of clinical studies with high scientific evidence that establish safety and efficacy of Cannabis products. This study aimed to comprehensively analyze how knowledge has been created in this field, as well as perform a bibliographic mapping to identify knowledge gaps, and investigate key authors and journals that have significantly contributed to advancing our understanding of Cannabis . Method: The study protocol was registered in the International Prospective Register of Systematic Review (CRD42020223084). A systematic search was conducted in the Cochrane Central Register of Controlled Trials, Lilacs, Google Scholar, PubMed, SciELO, Scopus, and Web of Science databases. The bibliographic analysis and mapping were registered using the VOSviewer, Sci2tool, CiteSpace, and PoP software. Results: The systematic search identified 27,597 records, with 17,020 duplicates, resulting in a total of 10,577 articles included. The authors who published the most were Marilyn Ann Huestis ( n =108) and Sagnik Bhattacharyya ( n =71), while Elisaldo A. Carlini and Raphael Mechoulam published 8 and 22 articles, respectively. The journals Drug and Alcohol Dependence ( n =297), Psychopharmacology ( n =159) and Addictive Behaviors ( n =150) were the ones that published the most on Cannabis . The journals suggest that the articles are correlated with the adverse and toxicological effects of recreational Cannabis use; however, most articles focus on medical Cannabis . The peak of publications was in 2021 ( n =1,481). The countries that published the most were the United States ( n =9,735), while Brazil occupied the 11th position ( n =422). Most publications were carried out in “Pharmacology and Pharmacy” (11.31%), followed by “Psychiatry” (7.66%) and “Medicine” (5.80%). The areas of “Neurosciences” (1.59%), “Biochemistry,” “Genetics,” and “Molecular Biology” (0.79%) were little explored. Conclusion: This study captured the characteristics of publications about Cannabis and clinical studies in the scientific literature, yielding >10,000 articles, representing a large literature review, to date. Therefore, the most productive countries included the United States, the United Kingdom, and Canada, while the most productive authors were Marilyn Ann Huestis and Sagnik Bhattacharyya, with a peak of publications in 2021. Finally, the most chosen journals were Drug and Alcohol Dependence and Psychopharmacology .
- Open Access
- 8 November 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (15)
Is turbo-extraction an efficient method for obtaining cannabinoids?
Cannabis-based products are still not produced in many countries and the great need makes them imported, and often expensive. As an objective, a low-cost extraction method was proposed to facilitate access to the medicinal effects of cannabidiol. The samples of Cannabis sativa used were obtained from in vitro cultivation or from commercially purchased products. Two extraction techniques (ultrasonic extraction and turbo-extraction) and two solvent systems (methanol:chloroform and ethanol) were evaluated. The levels of cannabinoids, total phenolics and total flavonoids were evaluated. The best results were obtained with the turbo-extraction. Ethanol showed a higher yield of cannabinoids, in addition to being a solvent accepted in international conventions in reducing the use of toxic solvents to the environment. Turbo-extraction with ethanol proved to be effective, economical and in line with environmental concerns in the use of ecologically sustainable solvents. As future possibilities, it is proposed to use the information obtained in this study as part of the process of obtaining and subsequent analysis of Cannabis extracts for medicinal purposes.
- 8 November 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (15)
Open AccessIs turbo-extraction an efficient method for obtaining cannabinoids?
Cannabis-based products are still not produced in many countries and the great need makes them imported, and often expensive. As an objective, a low-cost extraction method was proposed to facilitate access to the medicinal effects of cannabidiol. The samples of Cannabis sativa used were obtained from in vitro cultivation or from commercially purchased products. Two extraction techniques (ultrasonic extraction and turbo-extraction) and two solvent systems (methanol:chloroform and ethanol) were evaluated. The levels of cannabinoids, total phenolics and total flavonoids were evaluated. The best results were obtained with the turbo-extraction. Ethanol showed a higher yield of cannabinoids, in addition to being a solvent accepted in international conventions in reducing the use of toxic solvents to the environment. Turbo-extraction with ethanol proved to be effective, economical and in line with environmental concerns in the use of ecologically sustainable solvents. As future possibilities, it is proposed to use the information obtained in this study as part of the process of obtaining and subsequent analysis of Cannabis extracts for medicinal purposes.
- Open Access
- 6 June 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (8)
Can propolis and their compounds be efficacy in the treatment of coronavirus disease 2019 (COVID-19)? A systematic review
Despite the advancement of vaccination and the reduction in the number of deaths, there is still the emergence of new variants, such as the omicron of SARS-CoV-2 (COVID-19). In this sense, new natural antiviral therapies are highly explored. One of these products, propolis, have shown promising results against COVID-19, including the inhibition of the binding between the coronavirus and ACE2. This systematic review aimed to gather a summary of scientific evidence existing on the effective of the therapeutic use of propolis and their components in the treatment of COVID-19. The protocol for the present systematic review was registered on the PROSPERO (CRD42021267016). In this study, we analyzed 185 articles, selecting 13 of them. Some phenolic compounds and flavonoids, such as artepillin C, hesperetin, CAPE and rutin, were widely cited, as they have great potential for binding with the molecular targets of SARS-CoV-2. Some clinical studies that evaluated the effects of propolis against COVID-19 were included, and confirmed the effectiveness of propolis and its components. The results of this review demonstrate the effectiveness of using propolis and their components in the treatment of COVID-19 due to its antiviral activities. Additionally, the anti-inflammatory and immunomodulatory properties can help to patients with COVID-19.
- 6 June 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (8)
Open AccessCan propolis and their compounds be efficacy in the treatment of coronavirus disease 2019 (COVID-19)? A systematic review
Despite the advancement of vaccination and the reduction in the number of deaths, there is still the emergence of new variants, such as the omicron of SARS-CoV-2 (COVID-19). In this sense, new natural antiviral therapies are highly explored. One of these products, propolis, have shown promising results against COVID-19, including the inhibition of the binding between the coronavirus and ACE2. This systematic review aimed to gather a summary of scientific evidence existing on the effective of the therapeutic use of propolis and their components in the treatment of COVID-19. The protocol for the present systematic review was registered on the PROSPERO (CRD42021267016). In this study, we analyzed 185 articles, selecting 13 of them. Some phenolic compounds and flavonoids, such as artepillin C, hesperetin, CAPE and rutin, were widely cited, as they have great potential for binding with the molecular targets of SARS-CoV-2. Some clinical studies that evaluated the effects of propolis against COVID-19 were included, and confirmed the effectiveness of propolis and its components. The results of this review demonstrate the effectiveness of using propolis and their components in the treatment of COVID-19 due to its antiviral activities. Additionally, the anti-inflammatory and immunomodulatory properties can help to patients with COVID-19.